Michael R. Hughes
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Functional targeting of ILC2s and ILC3s reveals selective roles in intestinal fibrosis and homeostasis.
Journal: The Journal of experimental medicine
Published: September 10, 2024
Microbial intestinal dysbiosis drives long-term allergic susceptibility by sculpting an ILC2-B1 cell-innate IgE axis.
Journal: The Journal of allergy and clinical immunology
Published: February 27, 2024
A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinoma.
Journal: Frontiers in oncology
Published: August 31, 2023
Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes.
Journal: Frontiers in immunology
Published: August 02, 2022
Antibody-Drug Conjugates Targeting Tumor-Specific Mucin Glycoepitopes.
Journal: Frontiers in bioscience (Landmark edition)
Published: July 16, 2022
Platelet signaling at the nexus of innate immunity and rheumatoid arthritis.
Journal: Frontiers in immunology
Published: June 24, 2022
"Just one word, plastic!": Controversies and caveats in innate lymphoid cell plasticity.
Journal: Frontiers in immunology
Published: May 18, 2022
Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models.
Journal: Frontiers in oncology
Published: January 17, 2022
Last Updated: 09/26/2026